Company intelligence / Profile preview

Benova Innovative Medicine Research

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Benova Innovative Medicine Research is a clinical-stage biotechnology company focused on the discovery and development of original, small-molecule drugs that modulate the innate immune system. The company leverages its proprietary technology platforms to target pathways such as TLR7/8, STING, and ENPP1 to treat cancer and chronic viral infections. Its lead programs include dual TLR7/8 agonists and STING agonists designed to enhance anti-tumor immune responses. Benova operates research and development facilities in Suzhou and Shanghai, China, aiming to provide innovative therapeutic solutions for unmet medical needs in oncology and infectious diseases.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Benova Innovative Medicine Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benova Innovative Medicine Research.

Explore the full profile